Companies: 10,795·Total market cap: $144.5T
ImageneBio Inc

ImageneBio Inc

IMANASDAQHealthcare● Active
$5.52
$-0.11(-1.95%)
Market Cap$62260798
P/E Ratio
52W High$18
52W Low$3.94

ImageneBio Inc (IMA) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · IMA · as of Jun 9, 2026

Activity summary

Buy transactions

7

P-Purchase only

Sell transactions

0

12 Months

Buy/Sell ratio

Buy/Sell (by trades)

Overall sentiment

BULLISH
↑ Buy 100%Active transactions only · RSU vesting excluded0% Sell ↓

ImageneBio Inc insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 9, 2026

IMA insider buying and selling by quarter

IMA insider selling · IMA insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling
2.5M1.3M0
2025 Q3
2025 Q4
2026 Q1
2026 Q2

Mobile shows last 4Q · Desktop shows full 8Q

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 9, 2026

Active insiders

Most active in past 12 months · IMA ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

IMA executive sell shares · IMA board member insider trading · IMA insider trading SEC filing

Showing 26 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Yarema Kristin

CEO · Director

Award

Date

Mar 16

Shares

85,400

Price

Value

View Form 4 on SEC.gov

Butler Erin

PAO

Award

Date

Dec 30

Shares

22,500

Price

Value

View Form 4 on SEC.gov

SLATTERY JOSEPH P

Director

Purchase

Date

Dec 24

Shares

16,000

Price

$5.99

Value

$96K

View Form 4 on SEC.gov

Wang Stephen Hui

Director

Award

Date

Jul 25

Shares

188,042

Price

Value

View Form 4 on SEC.gov

Wang Stephen Hui

Director

Award

Date

Jul 25

Shares

50,144

Price

Value

View Form 4 on SEC.gov

Wang Stephen Hui

Director

Award

Date

Jul 25

Shares

12,535

Price

Value

View Form 4 on SEC.gov

Wang Jonathan Jian

Director

Award

Date

Jul 25

Shares

971,173

Price

Value

View Form 4 on SEC.gov

Wang Jonathan Jian

Director

Award

Date

Jul 25

Shares

143,832

Price

Value

View Form 4 on SEC.gov

ORBIMED ADVISORS LLC

Director

Award

Date

Jul 25

Shares

83,611

Price

$2.49

Value

$208K

View Form 4 on SEC.gov

Bonita David P

Director

Purchase

Date

Jul 25

Shares

83,611

Price

$29.90

Value

$2.50M ⚡

View Form 4 on SEC.gov

Bonita David P

Director

Option

Date

Jul 25

Shares

379

Price

Value

View Form 4 on SEC.gov

Stampacchia Otello

Director

Purchase

Date

Jul 25

Shares

267,556

Price

$29.90

Value

$8.00M ⚡

View Form 4 on SEC.gov

Stampacchia Otello

Director

Option

Date

Jul 25

Shares

379

Price

Value

View Form 4 on SEC.gov

Marango Jotin

CFO

Award

Date

Jul 28

Shares

15,776

Price

Value

View Form 4 on SEC.gov

Marango Jotin

CFO

Other

Date

Jul 28

Shares

4,630

Price

$17.16

Value

$79K

View Form 4 on SEC.gov

Butler Erin

PAO

Award

Date

Jul 25

Shares

3,051

Price

Value

View Form 4 on SEC.gov

ORBIMED ADVISORS LLC

Director

Award

Date

Aug 4

Shares

153,121

Price

Value

View Form 4 on SEC.gov

ORBIMED ADVISORS LLC

Director

Purchase

Date

Jun 24

Shares

96,035

Price

$5.37

Value

$516K

View Form 4 on SEC.gov

ORBIMED ADVISORS LLC

Director

Purchase

Date

Jun 24

Shares

65,965

Price

$4.37

Value

$288K

View Form 4 on SEC.gov

ORBIMED ADVISORS LLC

Director

Purchase

Date

Jun 23

Shares

23,419

Price

$3.71

Value

$87K

View Form 4 on SEC.gov

ORBIMED ADVISORS LLC

Director

Purchase

Date

Jun 22

Shares

66,806

Price

$3.55

Value

$237K

View Form 4 on SEC.gov

OrbiMed Genesis GP LLC

Director

Purchase

Date

Jun 22

Shares

66,806

Price

$3.55

Value

$237K

View Form 4 on SEC.gov

Bonita David P

Director

Purchase

Date

Jun 24

Shares

96,035

Price

$5.37

Value

$516K

View Form 4 on SEC.gov

Bonita David P

Director

Purchase

Date

Jun 24

Shares

65,965

Price

$4.37

Value

$288K

View Form 4 on SEC.gov

Bonita David P

Director

Purchase

Date

Jun 22

Shares

23,419

Price

$3.71

Value

$87K

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 2

Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About IMA insider trading

IMA insider trades

ImageneBio Inc (IMA) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Wang Stephen Hui (Director), Butler Erin (PAO), Wang Jonathan Jian (Director). Over the past 12 months, 5 insiders have filed transactions with the SEC. IMA insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For ImageneBio Inc's institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic
acquisitionOrDisposition field:
A = Acquisition (buy) · D = Disposition (sell)
RSU vesting (M-Exempt) excluded from sentiment
Form 4SEC filing required within 2 business days of any insider transaction
10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot
Open MktDirect purchase or sale on the open market (excludes awards, options)

Frequently asked questions

IMA insider trading · 5 questions

The insiders of ImageneBio Inc (IMA) include executives and directors such as Wang Stephen Hui (Director), Butler Erin (PAO), Wang Jonathan Jian (Director), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

IMA board member insider tradingwho are IMA insidersIMA insider rosterImageneBio Inc executives insider activity

Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026